SIREN : 484145487
PETNET SOLUTIONS SAS is a French company founded 20 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in LISSES (91090), this company of category GE shows in 2025 a revenue of 18.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18 886 404 € | 16 975 302 € | 13 855 820 € | 10 572 412 € | 10 640 721 € | 9 546 854 € | 9 779 949 € | 8 710 155 € | 7 504 899 € | 6 759 681 € |
| Net income | 4 103 171 € | 2 234 651 € | 2 701 075 € | 1 785 888 € | 1 952 101 € | 1 110 138 € | 1 516 598 € | 1 362 071 € | 1 115 586 € | 872 687 € |
| EBITDA | 7 462 455 € | 6 091 544 € | 5 751 438 € | 3 245 070 € | 3 935 528 € | 2 883 835 € | 3 467 763 € | 3 070 725 € | 1 898 756 € | 2 040 810 € |
| Net margin | 21.7% | 13.2% | 19.5% | 16.9% | 18.3% | 11.6% | 15.5% | 15.6% | 14.9% | 12.9% |
In 2025, PETNET SOLUTIONS SAS achieves revenue of 18.9 M€. Over the period 2016-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +12.1%. Vs 2024, growth of +11% (17.0 M€ -> 18.9 M€). After deducting consumption (237 k€), gross margin stands at 18.6 M€, i.e. a rate of 99%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 7.5 M€, representing 39.5% of revenue. Positive scissor effect: EBITDA margin improves by +3.6 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 4.1 M€, i.e. 21.7% of revenue. This profit can be retained or distributed to shareholders.
18 886 404 €
18 649 391 €
7 462 455 €
4 153 043 €
4 103 171 €
39.5%
The debt ratio (= Financial debt / Equity x 100) stands at 75%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.4 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 28.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
74.571%
54.322%
28.316%
6.419
38.3%
In 2025, the debt ratio of PETNET SOLUTIONS SAS (74.57) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2025, the financial autonomy of PETNET SOLUTIONS SAS (54.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of PETNET SOLUTIONS SAS (6.42) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 239.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 12.2x. Operating income very largely covers interest expenses: high safety margin.
239.393
12.237
In 2025, the liquidity ratio of PETNET SOLUTIONS SAS (239.39) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2025, the interest coverage of PETNET SOLUTIONS SAS (12.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 70 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 48 days. The company must finance 22 days of gap between collections and payments. Inventory turnover is 13 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 84 days of revenue, i.e. 4.4 M€ to permanently finance. Over 2016-2025, WCR increased by +169%, requiring additional financing.
4 392 600 €
70 j
48 j
13 j
84 j
Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 818 661€ to 2 516 245€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PETNET SOLUTIONS SAS with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques
The revenue of PETNET SOLUTIONS SAS in 2025 is 18.9 M€.
Yes, PETNET SOLUTIONS SAS generated a net profit of 4.1 M€ in 2025.
The headquarters of PETNET SOLUTIONS SAS is located in LISSES (91090), in the department Essonne.
The tax return of PETNET SOLUTIONS SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PETNET SOLUTIONS SAS operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.